Real-time qPCR analyses confirmed that the ectopic expression of ZBTB18 in a GBM cell line (SNB19) and in the primary GBM stem cell line BTSC233 downregulated CCL2, GDF15, and CX3CL1 genes (Fig. 1b). The gene discussed is CCL2; the disease is glioblastoma.